11/29/2010

Notice of investments in China

11/16/2010

Notice of Increasing the Capital of Shanghai Genomics

10/20/2010

GNI Receives F351 Patent Allowance in Japan

09/17/2010

Shanghai Genomics Issued US Patent Covering F351

08/26/2010

GNI Receives F351 Patent Allowance in Canada

07/30/2010

Notice of reaching agreement for co-development of F351 in China

07/26/2010

Shanghai Genomics Reports Human Phase I Trial Data of F351

06/21/2010

Shanghai Genomics Ltd. and Immuno-Biological Laboratories Co., Ltd. Signed Licensing Agreement to Explore Chinese Market

04/12/2010

Notice of Exercise Price of Stock Option etc

03/26/2010

Notice of Granting Stock Option to Board of Directors

03/26/2010

Notice of Granting Stock Option to Consultants

03/26/2010

Notice of Granting Stock Option to Employee

03/17/2010

Amendment of Pre-IND Studies of F1013 For Liver Failure Initiated In China And Update On Drug Pipeline Development

03/15/2010

Pre-IND Studies of F1013 For Liver Failure Initiated In China And Update On Drug Pipeline Development

02/23/2010

Update On Progress Of F647 NDA Filing